市场调查报告书
商品编码
1375110
北美微生物纤维素市场预测至 2028 年 - COVID-19 影响和区域分析 - 按应用(食品和饮料、食品包装、生物医学、化妆品等)North America Microbial Cellulose Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Application (Food & Beverages, Food Packaging, Biomedical, Cosmetics, and Others) |
2022年北美微生物纤维素市场价值为64.1611亿美元,预计2028年将达到124.3567亿美元;预计2022年至2028年复合年增长率为11.7%。
医疗保健产业对微生物纤维素的需求不断增加
微生物纤维素已引起生物医学和医疗保健行业的广泛关注。微生物纤维素是由緻密编织的三维网状奈米纤维组成。它具有优异的水结合能力、高拉伸强度和低血栓形成性。在伤口敷料中用作人体软组织修復材料。在严重烧伤的情况下,微生物纤维素可以作为极好的伤口癒合剂,因为它有助于伤口癒合和表皮再生的过程。
此外,微生物纤维素具有低过敏性、无细胞毒性和无刺激性,并且在难以触及的伤口和损伤中表现出完美的皮肤黏附力。微生物纤维素是人造血管和心血管部件的理想材料,因为它完美适应不规则的解剖轮廓。对于糖尿病患者,微生物纤维素用于糖尿病足和静脉溃疡的敷料。微生物纤维素也应用于组织工程中,以製造软骨组织植入物、角膜植入物、硬脑膜植入物和其他医疗植入物。製造商正在开发产品来满足医疗保健和製药业对微生物纤维素不断增长的需求。因此,微生物纤维素在医疗保健行业的广泛应用推动了其需求,从而促进了微生物纤维素市场的成长。
北美微生物纤维素市场概况
北美的微生物纤维素市场分为美国、加拿大和墨西哥。由于塑胶和聚合物、水泥添加剂、医疗保健、食品和饮料以及化妆品等各种最终用途行业的需求不断增加,北美为微生物纤维素製造商提供了许多成长机会。美国食品药物管理局 (FDA) 认为微生物纤维素是 GRAS(通常被认为是安全的)食品添加物。它用于传统甜点、植物性肉类、低胆固醇饮食、食品/饮料添加剂、食品包装等。北美纺织业正在进行研发活动,并与其他市场参与者合作,开发由细菌纤维素製成的环保、永续产品。例如,2022 年 5 月,总部位于加州的 von Holzhausen 公司与澳洲领先的研发公司 Nanollose 签署了一项合作协议,以利用细菌纤维素开发下一代纯素皮革。同样,2022 年 5 月,亚什兰全球控股公司推出了「natrathix」生物纤维素,这是一种源自天然、可生物降解的皮肤护理增稠剂。该地区主要参与者的此类倡议正在促进市场成长。
北美微生物纤维素市场收入及 2028 年预测(百万美元)
北美微生物纤维素市场细分
北美微生物纤维素市场根据应用和国家进行细分。根据应用,北美微生物纤维素市场分为食品和饮料、食品包装、生物医学、化妆品等。 2022 年,食品和饮料领域占据最大的市场。
依国家划分,北美微生物纤维素市场分为美国、加拿大和墨西哥。 2022年,美国将主导北美微生物纤维素市场。
阿什兰公司; Axcelon 生物聚合物公司;细菌纤维素解决方案公司;纤维素实验室公司;和 Polybion SL 是北美微生物纤维素市场的领先公司。
The North America microbial cellulose market was valued at US$ 6,416.11 million in 2022 and is expected to reach US$ 12,435.67 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2022 to 2028.
Increasing Demand for Microbial Cellulose in Healthcare Industry
Microbial cellulose has gained significant attention across the biomedical & healthcare industry. Microbial cellulose is composed of a densely woven three-dimensional network nanofiber. It possesses excellent water-binding capacity, high tensile strength, and low thrombogenicity. It is used as a soft human tissue repair material in wound dressing. In cases of severe burns, microbial cellulose acts as an excellent wound-healing agent as it aids the process of wound healing and epidermal regeneration.
Moreover, microbial cellulose is hypoallergenic, noncytotoxic, and nonirritating, and shows perfect skin adhesion in hard-to-reach wounds and injuries. Microbial cellulose is an ideal material for prosthetic blood vessels and cardiovascular components since it adapts perfectly to irregular anatomical contours. For diabetic patients, microbial cellulose is used for the dressing of diabetic feet and venous ulcers. Microbial cellulose also finds application in tissue engineering to make cartilage tissue implants, cornea implants, dura implants, and other medical implants. Manufacturers are developing products that cater to the rising demand for microbial cellulose in the healthcare & pharmaceuticals industry. Thus, the widespread applications of microbial cellulose in the healthcare industry propel its demand, thereby bolstering the microbial cellulose market growth.
North America Microbial Cellulose Market Overview
The microbial cellulose market in North America is segmented into the US, Canada, and Mexico. North America holds many growth opportunities for microbial cellulose manufacturers owing to increasing demand from various end-use industries such as plastics & polymers, cement additives, healthcare, food & beverages, and cosmetics. The US Food Drugs and Administration (FDA) considers microbial cellulose a GRAS (generally recognized as safe) food additive. It is used in conventional desserts, plant-based meat, low cholesterol diet, food/beverage additives, food packaging, and others. The textile industry in North America is conducting research & development activities and collaborating with other market players to develop eco-friendly, sustainable products made from bacterial cellulose. For instance, in May 2022, von Holzhausen, a California-based company, signed a collaboration agreement with Nanollose, a leading Australia-based research and development company, to develop next-gen vegan leather from bacterial cellulose. Similarly, in May 2022, Ashland Global Holdings Inc. launched 'natrathix' bio cellulose, a nature-derived, biodegradable thickener for skin care. Such initiatives by key players in the region are contributing to the market growth.
North America Microbial Cellulose Market Revenue and Forecast to 2028 (US$ Million)
North America Microbial Cellulose Market Segmentation
The North America microbial cellulose market is segmented based on application and country. Based on application, the North America microbial cellulose market is segmented into food & beverages, food packaging, biomedical, cosmetics, and others. The food & beverages segment held the largest market share in 2022.
Based on country, the North America microbial cellulose market is segmented into the US, Canada, and Mexico. The US dominated the North America microbial cellulose market share in 2022.
Ashland Inc; Axcelon Biopolymers Corp; Bacterial Cellulose Solutions Inc; Cellulose Lab Inc; and Polybion SL are the leading companies operating in the North America microbial cellulose market.